Skip to main content

Heska Corp

HSKADelisted Jun 13, 2023
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0001038133

Heska Corp was delisted on Jun 13, 2023; its insiders filed their last Form 4 on Jun 14, 2023; 152 institutions reported holding it in 13F filings for Q1 2023, worth $1.01B in total; no superinvestor held it.

Q4 2022 vs. Q3 2022

How the institutions holding Heska Corp changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of HSKA: Q3 2022 compared with Q4 2022
MeasureQ3 2022Of which not filed for Q4 2022Q4 2022Change
Holders1672154−11
Shares10.7M6410.4M−278.9K (−2.6%)
Value$781.2M$5.02K$649.1M−$132.1M (−16.9%)

2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (12)

Institutions that held Heska Corp at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to HSKA in Q4 2022
InstitutionSharesValue% of portfolio
Sio Capital Management, LLC84,309$5.24M2.79%
Numerai GP LLC8,849$550.1K0.38%
Petrus Trust Company, LTA7,273$452.1K0.06%
Maryland State Retirement & Pension System4,159$258.5K0.01%
FNY Investment Advisers, LLC300$18.0K0.03%
Park Place Capital Corp151$9.00K0.00%
EverSource Wealth Advisors, LLC121$7.52K0.00%
Allworth Financial LP31$1.93K0.00%
IFP Advisors, Inc7$1.00K0.00%
Money Concepts Capital Corp4$2490.00%
Versant Capital Management, Inc4$2490.00%
American National Bank3––

Sold out (23)

Institutions that held Heska Corp at the end of Q3 2022 and filed for Q4 2022 without it.

Not filed for Q4 2022 yet (2)

Institutions that held Heska Corp at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding HSKA in Q3 2022 that haven't filed for Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Wipfli Financial Advisors LLC,50$4.00K
American Portfolios Advisors14$1.02K